The Harvard Drug Group has acquired 2 companies of its own. It has also divested 1 asset.
The Harvard Drug Group’s largest acquisition to date was in 2012, when it acquired The Rugby Group for $117M. It’s largest disclosed sale occurred in 2022, when it sold Letco Medical to Fagron NV for $34M. The Harvard Drug Group has acquired in 2 different US states. The Company’s most targeted sectors include distribution (50%) and medical products (50%).
Join Mergr and gain access to The Harvard Drug Group’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the distribution sector.
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2